πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,015 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8268786

Anti-cancer tocotrienol analogues and associated methods

First Tech International Limited Β· Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8258263

Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activiti

The Regents of the University of California Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8198322

Apoptotic and anti-tumor activities of metallo-salens

The Board of Regents of the University of Texas System Β· Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8192741

Method of treating rheumatoid arthritis with an anti-IL-6R antibody

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8187605

Means for the inhibition of anti-Ξ²1-adrenergic receptor antibodies

Julius-Maximilians-Universitat Wurzburg Β· Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8173673

Biofilm-inhibiting effect and anti-infective activity of N,C-linked aryl isoquinolines and

Julius-Maximilians-Universitat Wurzburg Β· Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8168591

Compositions and methods related to anti-FGF agents

The Regents of the University of California Β· Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8163509

Biological markers predictive of anti-cancer response to insulin-like growth factor-1 rece

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8143390

Compositions and methods for inhibiting expression of anti-apoptotic genes

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8137672

Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD

The Regents of the University of Colorado Β· Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8133859

SCGB3A2 as a growth factor and anti-apoptotic agent

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8128930

Anti-ADDL antibodies and uses thereof

Northwestern University Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8097713

Nucleic acid molecules which encode human anti-CD20 antibodies and methods of use thereof

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088908

Humanized anti-prostate stem cell antigen monoclonal antibody

The Regents of the University of California Β· Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088774

Anti-inflammatory and protein kinase inhibitor compositions and related methods for downre

Northwestern University Β· Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088729

Anti-viral griffithsin compounds, compositions and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8076372

Acythiols and component thiol compositions as anti-HIV and anti-retroviral agents

The Government of the United States Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8053422

Anti-cancer oligodeoxynucleotides

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039585

Therapeutic administration of the scrambled anti-angiogenic peptide C16Y

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039257

Pre-transplant accomodated organs resistant to anti-donor immunity

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8038997

Anti-marinobufagenin antibodies and methods for their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8029788

Variants of humanized anti-carcinoma MAb CC49

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8022175

Production of anti-peptide monoclonal antibodies to distinguish Exotic New Castle diseases

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8021644

Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-

The Regents of the University of California Β· Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted